Importance of Umbilical Cord Donation
Cord blood transplants hold promise for treating a wide range of diseases, from cancer and diabetes to rare genetic disorders. Within the cord blood are blood-forming stem cells, known as hematopoietic stem cells. Transplantation of these stem cells into patients with chronic or life-threatening diseases allows regrowth or regeneration of healthy cells.
Thus, cord blood stem cell transplants are a form of regenerative medicine, a branch of medicine that replaces, regrows, or repairs tissues damaged by disease, trauma, or congenital issues. Therefore, rather than treating the symptoms of a disease, regenerative medicine provides restorative, therapeutic, and even curative benefits to the patient.
Currently, there are nearly 80 diseases cord blood transplants can treat or potentially cure. As of this year, there are over 200 clinical trials worldwide investigating the use of cord blood stem cells in regenerative therapy and its effectiveness in the treatment of many blood disorders, as well as conditions unrelated to blood, such as cerebral palsy, gestational diabetes, Alzheimer’s, Autism, and stroke. If successful, these clinical trials may lead to the approval of new and better treatments from the Food and Drug Administration (FDA) for patients in need.
Advancement of clinical trials and final approval by the FDA for treatment depends on the innovative research conducted at academic institutions and within the biotech and pharmaceutical industries. Donor contributions, such as the donation of cord blood for research, fuels the progress of their research.
About Cord Blood
Cord blood is the leftover blood found within the baby’s umbilical cord and placenta immediately after birth. It is blood that is no longer needed to support the development of the baby and often goes into medical waste unless the mother decides to save the cord blood for public or private banking, or research purposes. The collection of cord blood is a safe, quick, and easy procedure that does not interfere with the birthing process or prevent a parent from taking the placenta home, if desired. Cord blood is drawn after the baby has been born, and the umbilical cord has been clamped and cut. Cord blood is only collected upon the consent of the mother.
Our Collection Procedures
Our well-trained technicians work side-by-side with the hospital nursing teams to create the most optimal process for cord blood collection. Once a patient is admitted to the labor and delivery unit, the mother is asked if she would like to consent to donate cord blood. Once a mother has consented and the baby is delivered, the placenta and umbilical cord are taken to a processing room where the technician draws the cord blood using our specialized collection unit. Once collected, the cord blood is sent to our laboratory for additional processing.
All StemExpress Foundation technicians have been trained in HIPAA, NIH consenting procedures, and hospital and blood-borne pathogen safety. Additionally, our collection process utilizes custom tools and techniques to achieve the largest possible draw volume, making every donation count.
Due to our specialized techniques and training, our cord blood collections are significantly higher than national averages for private blood banks. The Total Nucleated Cell (TNC) count is the standard unit of measure used to determine the number of nucleated cells within the cord blood. The documented private banking national average for cord blood collection is 0.47x10^9 TNC and 60ml of volume.
Our average cord blood results yield 0.79x10^9 TNC and 90mls of volume. These higher cell yields significantly increase opportunities for life-saving research.
Partner With The StemExpress Foundation
Through StemExpress Foundation, your facility can participate in life-changing medical research. We offer onsite training to ensure that the collection process has little to no impact on your regular business and patient care.